Sfoglia per Rivista DERMATOLOGIC THERAPY
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy
2021-01-01 Stingeni, L.; Hansel, K.; Antonelli, E.; Bello, G. D.; Patruno, C.; Napolitano, M.; Fabbrocini, G.; Grieco, T.; Pellacani, G.; Fargnoli, M. C.; Esposito, M.; Piras, V.; Zucca, M.; Girolomoni, G.
The Combination of Dupilumab with Other Monoclonal Antibodies.
2023-01-01 Gisondi, P; Maurelli, M; Costanzo, A; Esposito, M; Girolomoni, G.
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
2019-01-01 Spallone, G.; Sollena, P.; Ventura, A.; Fargnoli, M. C.; Gutierrez, C.; Piccerillo, A.; Tambone, S.; Bianchi, L.; Peris, K.
Italian expert consensus paper on the management of patients with actinic keratoses
2020-01-01 Moscarella, E.; Di Brizzi, E. V.; Casari, A.; De Giorgi, V.; Di Meo, N.; Fargnoli, M. C.; Lacarrubba, F.; Micali, G.; Pellacani, G.; Peris, K.; Piaserico, S.; Calzavara-Pinton, P.; Quaglino, P.; Sollena, P.; Zalaudek, I.; Zane, C.; Argenziano, G.
Ixekizumab improves disease severity, clinical symptoms and quality of life in patients with genital psoriasis: A 24-week real-life experience
2021-01-01 Calianno, G.; Esposito, M.; Fidanza, R.; Palmieri, M.; Fargnoli, M. C.
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment.
2011-01-01 Renzo, Ld; Saraceno, R; Schipani, C; Rizzo, M; Bianchi, A; Noce, A; Esposito, Maria; Tiberti, Sergio; Chimenti, S; DE Lorenzo, A.
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study
2022-01-01 Colombo, D.; Bianchi, L.; Fabbrocini, G.; Corrao, S.; Offidani, A.; Stingeni, L.; Costanzo, A.; Pellacani, G.; Peris, K.; Bardazzi, F.; Argenziano, G.; Ruffolo, S.; Dapavo, P.; Carrera, C.; Fargnoli, M. C.; Parodi, A.; Romanelli, M.; Malagoli, P.; Talamonti, M.; Megna, M.; Raspanti, M.; Paolinelli, M.; Hansel, K.; Narcisi, A.; Conti, A.; De Simone, C.; Chessa, M. A.; De Rosa, A.; Provenzano, E.; Ortoncelli, M.; Moltrasio, C.; Fidanza, R.; Burlando, M.; Tonini, A.; Gaiani, F. M.; Simoni, L.; Ori, A.; Fiocchi, M.; Zagni, E.
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study
2021-01-01 Esposito, M.; Giunta, A.; Gisondi, P.; Tambone, S.; Rovaris, M.; Manfreda, V.; Pirro, F.; Pellegrini, C.; Fargnoli, M. C.; Bianchi, L.; Peris, K.; Girolomoni, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy | 1-gen-2021 | Stingeni, L.; Hansel, K.; Antonelli, E.; Bello, G. D.; Patruno, C.; Napolitano, M.; Fabbrocini, G.; Grieco, T.; Pellacani, G.; Fargnoli, M. C.; Esposito, M.; Piras, V.; Zucca, M.; Girolomoni, G. | |
| The Combination of Dupilumab with Other Monoclonal Antibodies. | 1-gen-2023 | Gisondi, P; Maurelli, M; Costanzo, A; Esposito, M; Girolomoni, G. | |
| Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities | 1-gen-2019 | Spallone, G.; Sollena, P.; Ventura, A.; Fargnoli, M. C.; Gutierrez, C.; Piccerillo, A.; Tambone, S.; Bianchi, L.; Peris, K. | |
| Italian expert consensus paper on the management of patients with actinic keratoses | 1-gen-2020 | Moscarella, E.; Di Brizzi, E. V.; Casari, A.; De Giorgi, V.; Di Meo, N.; Fargnoli, M. C.; Lacarrubba, F.; Micali, G.; Pellacani, G.; Peris, K.; Piaserico, S.; Calzavara-Pinton, P.; Quaglino, P.; Sollena, P.; Zalaudek, I.; Zane, C.; Argenziano, G. | |
| Ixekizumab improves disease severity, clinical symptoms and quality of life in patients with genital psoriasis: A 24-week real-life experience | 1-gen-2021 | Calianno, G.; Esposito, M.; Fidanza, R.; Palmieri, M.; Fargnoli, M. C. | |
| Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. | 1-gen-2011 | Renzo, Ld; Saraceno, R; Schipani, C; Rizzo, M; Bianchi, A; Noce, A; Esposito, Maria; Tiberti, Sergio; Chimenti, S; DE Lorenzo, A. | |
| Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study | 1-gen-2022 | Colombo, D.; Bianchi, L.; Fabbrocini, G.; Corrao, S.; Offidani, A.; Stingeni, L.; Costanzo, A.; Pellacani, G.; Peris, K.; Bardazzi, F.; Argenziano, G.; Ruffolo, S.; Dapavo, P.; Carrera, C.; Fargnoli, M. C.; Parodi, A.; Romanelli, M.; Malagoli, P.; Talamonti, M.; Megna, M.; Raspanti, M.; Paolinelli, M.; Hansel, K.; Narcisi, A.; Conti, A.; De Simone, C.; Chessa, M. A.; De Rosa, A.; Provenzano, E.; Ortoncelli, M.; Moltrasio, C.; Fidanza, R.; Burlando, M.; Tonini, A.; Gaiani, F. M.; Simoni, L.; Ori, A.; Fiocchi, M.; Zagni, E. | |
| Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study | 1-gen-2021 | Esposito, M.; Giunta, A.; Gisondi, P.; Tambone, S.; Rovaris, M.; Manfreda, V.; Pirro, F.; Pellegrini, C.; Fargnoli, M. C.; Bianchi, L.; Peris, K.; Girolomoni, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile